Mucosa-associated lymphoid tissue (MALT)lymphomais often mis-diagnosed as a benign tumor. Dissemination to other sites occurs in MALT lymphoma.Wereport a 60-year-old manwith gastric and pulmonary tumors of MALT lymphomawhich occurred 5 years apart. Initially, the gastric tumor had been diagnosed as reactive lymphoreticular hyperplasia. To determine whether the two tumors arose from the same malignant clone, we amplified and sequenced the complementarity-determining region 3 of the immunoglobulin heavy chain gene using the polymerase chain reaction (PCR). The sequences were identical except for ll-nucleotide difference, suggesting identical clonality. (Internal Medicine 34: 220-223, 1995) 
Introduction
Mucosa-associated lymphoid tissue (MALT)lymphoma is one of the low-grade B-cell lymphomas (1) . It occurs in the gastro-intestinal tract, lung, salivary gland, and thyroid, and usually remains at the primary site (2) . The disease is characterized by indolent progression leading to a prolonged clinical course (2) . The tendency to remain at the primary site and specific dissemination to other mucosal sites are characteristic features of MALTlymphoma that are poorly understood. The diagnosis of MALT lymphoma is difficult to make sometimes, and MALTis frequently mis-diagnosed as reactive lymphoreticular hyperplasia (RLH) or some other benign tumor, as the abnormal centrocyte-like cells surrounding the normal reactive B-cell follicles are few.
Recent progress in molecular biological analysis has made it possible to detect small monoclonal B-cell populations in paraffin-embedded tissues using the polymerase chain reaction (PCR). In B-cell malignancies, amplification by PCR of the complementarity-determining region 3 (CDR3) that is generated by V-D-Jjoining of the immunoglobulin heavy chain gene is useful (3, 4) for the demonstration of monoclonality of the disease. By sequencing the CDR3 of separate tumors, it is possible to determine whether the malignant cells are derived from the same origin, since the pattern ofV-D-Jjoining is very variable and is specific for each B-cell clone. Here we report a patient who had MALTlymphomain the stomach which was diagnosed initially as RLH and who developed the same type of MALTlymphoma 5 years later. We amplified and sequenced the respective CDR3regions of the two specimens to confirm clonality.
Case Report
A 60-year-old man was admitted to an affiliated hospital complaining of epigastric discomfort. A large submucosal tumor was found in the stomach, and a gastrectomy was performed. The pathologic diagnosis of the excised tumor was RLH. The patient was followed without any further therapy. Five years later he was readmitted to our hospital because of an abnormality seen on a chest roentgenogramordered as part of a routine examination. Chest radiographs revealed alveolar shadows in the right lower lung field. As no pathogenic bacteria were detected on sputum culture, and treatment with antibiotics did not show any improvement, a transbronchial lung biopsy (TBLB)was performed to evaluate the cause of the alveolar process. The pathologic diagnosis of the TBLBsamples was MALTlymphoma. A lobectomy was performed.
Materials and Methods

Pathologic analysis
Wereviewed formalin-fixed, paraffin-embedded sections of the gastric tumor and specimens of the excised lobe of the lung which were stained with hematoxylin and eosin (HE). The samples were obtained with informed consent.
PCR analysis
DNAswere extracted from paraffin-embedded samples of the gastric tumor using a method previously reported (5) and from the resected pulmonary lobe using the standard proteinase-phenol-chloroform method (6) . Approximately 0. 1 jag of DNAwas subjected to PCR(3). Semi-nested PCRwas performed to amplify the CDR3sequences, in which primers were directed to the joining region (first-round primer, LJH: 5'-TGAGGAGACGGTGACC-3 ' ; nested second-round primer, VLJH: 5 '-GTGACCAGGGTNCCTTGGCCCCAG-3') and to the conserved framework-three segment of the variable region
PCRconsisted of 3 minutes pre-heating at 94°C, 40 cycles of 1 minute denaturing at 94°C, 1 minute annealing at 55°C and 1 minute extension at 74°C, and a 10 minutes post-extension at 74°C. The PCR was performed on a PC-700 thermocycler (Astec, Tokyo, Japan). Products were electrophoresed using a 12% polyaerylamide gel, and the gel was stained with ethidium bromide.
Cloning and sequencing ofPCR products PCRproducts were ligated into pUC18 plasmid vectors using a Sure Clone PCR ligation kit (Pharmacia LKB, Tokyo, Japan). Nucleotide sequences were determined by fluorescence on an Autosequencer 373A (Applied BioSystem, Foster City, CA, USA) using vector-specific primers.
Results
The specimen of the gastric tumor which had been diagnosed initially as RLHshowed centrocyte-like cells infiltrating around reactive B-cell follicles with destruction of the epithelial layers. These findings are compatible with the histologic features of a low-grade B-cell lymphoma of the MALTtype (1) (Fig. 1A ).
Histologic examination of the' resected lung also revealed
MALTlymphoma with infiltration of medium-sized cells ( difficult to diagnose the disease correctly, and MALTlymphoma has been misdiagnosed frequently as other benign tumors (13).
In reactive B-cell hyperplasia, infiltrating lymphocytes do not have monoclonality, so that PCRanalysis shows a smearpattern (9, 14), while a single band is detected in MALTlymphoma. Therefore PCRanalysis is a very useful method to distinguish MALTlymphoma from other benign tumors, including RLH.
The immunoglobulinvariable region of the two tumors in this study showeddifferences between the stomach and lung samples in nucleotides at 1 1 positions. Since Taq DNApolymerase lacks a proof-reading function, somepoint mutations occur during the PCR procedure (5) . The frequency of a substitution of a nucleotide during a single cycle extension of PCRis estimated at 1/8000 (5). As we carried out 40 cycles of extension, the mutation rate in our amplification wasestimated at 1/200. The number of point mutations found in our study was far more than that expected from the PCR procedure. Therefore, it is reasonable to assume that these mutations occurred during the development of the disease. MALTlymphomahas been reported to be indolent, and to have a tendency to remain at the primary site. In the present ucts (Fig. 2) . The similar intensity of both bands may be a result of the plateau effect in PCR amplification. These findings suggest that the malignant cells from both tissue are monoclonal (8, 9 ).
As the bands from both samples had similar migration patterns, the sequences were determined to see whether or not the origin of the two tumors was the same. The nucleotide sequences of the samples were found to be identical in the V-DJjoining except for a difference of 1 1 nucleotides, one in the V region, one in the D region and nine in the N region (Fig. 3) . The patterns of V-D-J joining (10-12) of these samples indicated that both tumors arose from a commonclone.
Discussion
In this study we showed by PCRthat a gastric MALT lymphoma which had initially been diagnosed as RLH, and a pulmonary MALTlymphoma which had developed 5 years later in the same patient arose from the same clone.
In MALTlymphoma, normal reactive B-cell follicles exist, and only a few abnormalcentrocyte-like cells are seen surrounding the follicles. This pathohistologic feature makes it case, the patient developed a tumor in the lung, not in the primary site of the gastrointestinal tract. This indicates that dissemination to other sites occurs in MALTlymphoma.
Blazquez et al ( 1 5) have reported that mucosal dissemination to other sites occurs more frequently than has been previously reported. It is conceivable that there are many patients with MALT lymphoma who are mis-diagnosed initially with other benign tumors. In such cases, an initial correct diagnosis and appropriate treatment will improve the lymphomapatient's prognosis. Whena patient is diagnosed as having reactive B-cell hyperplasia, it is important to rule out the presence of monoclonality in the tumor by PCR.
